Sponsors (4)
The bill strengthens individual control and privacy over genetic data in bankruptcy estates by requiring notice and deletion, but it raises administrative costs, risks of temporary exposure, potential delays in asset sales, and the chance of litigation over retroactive application.
Individuals whose genetic data is in bankruptcy estates will receive required prior written notice before sale, use, or lease of their data, giving them more control over sensitive personal information.
Trustees and courts must delete genetic information not sold from estates, reducing the amount of sensitive genomic data retained and lowering the risk of breaches or misuse.
Trustees, purchasers, and courts gain clearer statutory rules for handling genetic data in bankruptcy, reducing legal uncertainty about obligations and permissible transactions.
Patients and others with genetic data in estates may still have sensitive information exposed during estate administration before it is deleted, and deletion standards could vary by court, leaving residual privacy and safety risks.
Creditors and financial institutions may face delays or blocks to sales of estate assets containing genetic data because of the notice requirement, prolonging bankruptcy cases and increasing administrative expenses.
Trustees (and ultimately estates/creditors) will incur additional administrative costs to provide notices and delete data, which could reduce estate recoveries available to creditors or beneficiaries.
Based on analysis of 2 sections of legislative text.
Adds genetic information to bankruptcy protections, requires prior written notice before sale/use/lease, and mandates deletion of remaining genetic data unless properly transferred.
Introduced July 17, 2025 by Benjamin Cline · Last progress July 17, 2025
Adds genetic information to the categories of personal data protected in bankruptcy cases, requires that trustees or debtors give actual prior written notice to each affected person before any sale, lease, or use of genetic information from the bankruptcy estate, and requires courts to order deletion of any genetic information remaining in the estate unless it was properly sold or otherwise disposed. The bill applies on enactment to pending, commenced, or reopened bankruptcy cases and recognizes NIST SP 800-88 as an acceptable deletion method.